BioBoard
Abstract
Ian Frazer Named Australian of the Year.
Further Funding For Australian Medical Research.
Blockbuster Gardisil Approved by FDA.
Potential Ovarian Cancer Diagnostic Test on Trial in Melbourne.
Seven Scientists Elected as CAS Foreign Members.
CAS and University of Tokyo Set up Joint Laboratories.
AstraZeneca to Invest $100 million in China.
Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS) Partner with the Danish Pharmaceutical Company Lundbeck.
Anti-flu Tamiflu Approved in China.
China Develops New Bird Flu Vaccines.
China Collaborates with WHO to Fight Infectious Diseases.
Apollo Hospitals Eyes Acquisition in South-East Asia.
India Opens New Free AIDS Therapy Centers.
Ranbaxy Faces Criminal Charges for Price-fixing of Antibiotics and Warfarin.
Nobel Laureate Norman E. Borlaug Calls for Gene Revolution in India.
Carlyle Asia Growth Partners III Raises US$668 Million to Support Emerging Asian Business Leaders with Expansion Capital.
Kyoto University and Summit Pharmaceuticals International Corp Collaborate.
Grain Crisis Looms in Japan.
University Student Named New Zealand's Young Scientist of the Year.
New Boost in New Zealand Biotech Industry.
HP and A*STAR to Open $30 Million R&D Lab.
A*STAR to Collaborate with Australian National University.
Singapore's BAC Announces Biomedical Research Data to be Off-limits to Third Parties.
